PT - JOURNAL ARTICLE AU - Padhi, Bijaya Kumar AU - Al-Mohaithef, Mohammed TI - Determinants of intent to uptake Coronavirus vaccination among respondents in Saudi Arabia: a web-based national survey AID - 10.1101/2020.05.27.20114413 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.27.20114413 4099 - http://medrxiv.org/content/early/2020/05/29/2020.05.27.20114413.short 4100 - http://medrxiv.org/content/early/2020/05/29/2020.05.27.20114413.full AB - Background Vaccine hesitancy is a potential threat to global public health. Since, there is an unprecedented global effort to develop a vaccine against the COVID-19 disease, much less is known about its acceptance in the community. Understanding key determinants that influence the preferences and demands of a future vaccine by the community may help to develop strategies for improving the global vaccination program. This study aimed to assess the prevalence of the acceptancy of COVID-19 vaccine, and their determinants among people in Saudi Arabia.Methods A web-based cross-sectional study was designed using snowball sampling strategies under a highly restricted environment. A bilingual, self-administered anonymous questionnaire was designed and send to 1000 study participants through social media platforms and email. Study participants were recruited across the country, including the four major cities (Riyadh, Dammam, Jeddah, and Abha) in Saudi Arabia. Associations between COVID-19 vaccine acceptance and sociodemographic profile of the respondents were explored using the chi-squared test. Key determinants in predicting vaccine acceptancy among respondents were modelled using logistic regression analysis.Results Of the 1000 survey invitees, 992 responded to the survey (response rate, 99.2%). The majority of the study participants (29.53%) were in the age group (36–45 years), and 65.8% were female, and 17.9% were Non-Saudi participants. Of the 992 respondents, 642 (64.72%) said they are interested in taking the COVID-19 vaccine once it is available. Willingness to accept a future COVID-19 vaccine is relatively high among older age groups (79.2% among 45+ year old), married participants (69.3%), participants with education levels of a postgraduate degree or higher (68.8%), non-Saudi (69.1%), workings with government sector (68.9%). In multivariate model, respondents who were above 45 years (aOR: 2.15; 95% CI: 1.08-3.21), and married (aOR: 1.79; 95% CI: 1.28-2.50) were significantly associated with vaccine acceptance (p < .05). Besides, people having trust in the health system were most likely to accept vaccination (aOR: 3.05; 95% CI: 1.13-4.92). Participants having a higher perceived risk of acquiring infection were 2.13 times higher odds of reporting their intention to uptake the COVID-19 vaccine (aOR: 2.13; 95% CI: 1.35-3.85).Conclusion Addressing sociodemographic determinants relating to the COVID-19 vaccination may help to increase uptake of the global vaccination program to tackle future pandemics. Targeted health education measures are needed among the general population to increase the uptake of the COVID-19 vaccine.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNilAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study approval was obtained from the Institutional Research Committee of Saudi Electronic University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Data is available with the corresponding author and can be provided upon request.